YieldMax MRNA Option Income Strategy ETF
$40.74-$0.26 (-0.63%)
YieldMax MRNA Option Income Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 15.02% below the high.
NYSE · DSMC · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:58 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Distillate Small/Mid Cash Flow ETF’s quoted price sits in the upper half of its reported 52-week range, 0.04% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Distillate Small/Mid Cash Flow ETF’s forward annual dividend is $0.49 per share, paid quarterly. The forward yield is 1.08% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
DSMC employs a disciplined strategy to pick its holdings, admitting only companies that satisfy its unique, internally developed benchmarks for cash-flow-based valuation and overall quality. The fund's initial universe for consideration encompasses roughly 1,000 profitable U.S. stocks from the small and mid-capitalization segments.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 08:07 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$40.74-$0.26 (-0.63%)
YieldMax MRNA Option Income Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 15.02% below the high.
$95.30-$6.52 (-6.4%)
Strive U.S. Semiconductor ETF’s quoted price sits in the upper half of its reported 52-week range, 23.56% below the high.
$16.69-$0.28 (-1.65%)
Defiance S&P 500 Target Income ETF’s quoted price sits in the lower half of its reported 52-week range, 8.55% below the high.
$28.22-$0.39 (-1.35%)
Hilton Small-MidCap Opportunity ETF’s quoted price sits in the lower half of its reported 52-week range, 9.47% below the high.
$15.46-$0.14 (-0.88%)
Conductor Global Equity Value ETF’s quoted price sits in the lower half of its reported 52-week range, 9.38% below the high.
$33.16+$0.01 (+0.02%)
Keating Active ETF’s quoted price sits in the upper half of its reported 52-week range, 6.12% below the high.
$24.71+$0.11 (+0.45%)
iShares iBonds Oct 2034 Term TIPS ETF’s quoted price sits in the lower half of its reported 52-week range, 6.9% below the high.
$29.38+$0.07 (+0.25%)
State Street SPDR Portfolio Treasury ETF’s quoted price sits in the lower half of its reported 52-week range, 5.1% below the high.